Sysmex partners with laboratories to deliver improved QC Management
Lincolnshire,
Ill. (July 11, 2017) Sysmex America, Inc., a leading provider of automated hematology
and urinalysis diagnostic testing equipment as well as middleware information
systems technology, today announced its latest innovation: a way to make
quality assurance easier and more risk free than manual quality control processes.
“Sysmex is well known for the innovation that it delivers to the laboratory.
BeyondCareSM Quality Monitor elevates quality assurance processes to
a new level with automated, continuous monitoring and guidance in an easy-to-use
framework,” said Ralph Taylor, chief executive officer.
BeyondCare
Quality Monitor is a web-based quality control and calibration verification
management program that uses evidence-based quality control targets and peer
group analytics to improve error detection and minimize false rejection of
control results - potentially saving both time and money for the laboratory.
The managed QC and calibration program has the potential to identify shifts and
trends in QC weeks sooner than traditional methods. Continuous calibration verification occurs
every time the QC is analyzed as opposed to every 6 months, further
streamlining the error detection process.
Reports are integral to the application, so documentation is easier and
there is less paper to print and file.
“Sysmex is excited to bring this innovation to
the laboratory industry. BeyondCare
Quality Monitor eliminates the repetitive and time-intensive nature of quality
assurance. One look at the screen and
the technologist will see if all is well or if QC has exceeded its target –
it’s all there in green, yellow and red,” said Andy Hay, chief operating
officer. “This simplifies a critical component
of delivering accurate patient results,” said Hay. Additional troubleshooting guidelines provided
on screen will also assist in resolution.
BeyondCare Quality Monitor will be standard on the new line of Sysmex XN-L™ automated hematology analyzers available in the United States. There are plans to extend the new service to other XN-Series™ hematology analyzers in the future.